2024-2032 年按产品、技术（生物晶片、凝胶卡、微孔板、聚合酶链反应、红血球磁化技术等）、应用、最终用户和地区分類的免疫血液学市场报告

IMARC Group年全球免疫血液学市场规模达19亿美元。

免疫血液学是医学科学的一个分支，研究血液和造血组织与免疫系统的关係。它用于研究血液中抗原的存在及其与可能导致溶血或红血球 (RBC) 凝集的抗体的反应。进行各种免疫血液学测试，以确保安全输血并预防不良的免疫、移植和妊娠相关反应，并诊断血液相关病症和疾病，如爱滋病毒、肝炎等。微孔板、生物晶片、凝胶卡、聚合酶炼式反应和红血球磁化技术（EMT）技术的试剂、自动和半自动分析仪。

全球范围内白血病和其他血液疾病盛行率的不断上升是推动市场成长的关键因素之一。此外，医疗基础设施的改善以及血库和创伤中心的发展，特别是在发展中国家，也推动了市场的成长。群众对血液采集、处理、检测和储存相关活动的认识不断提高，进一步对免疫血液学设备的需求产生了积极影响。此外，各种技术进步，例如创新输血系统和全自动设备的开发，也是其他生长诱导因素。这些新一代免疫血液学设备有助于提高诊断效率，最大限度地减少分析时间和人为错误的风险，并为患者提供紧急援助。其他因素，包括越来越多的捐血营和意识计划，以及医疗基础设施的改善，预计将进一步推动市场发展。

本报告回答的关键问题：

• 迄今为止，全球免疫血液学市场表现如何，未来几年将如何表现？
• 主要区域市场有哪些？
• COVID-19 对全球免疫血液学市场有何影响？
• 基于产品的市场区隔是什么？
• 基于技术的市场区隔是什么？
• 基于应用的市场区隔是什么？
• 基于最终用户的市场区隔是什么？
• 产业价值链的各个阶段是什么？
• 该行业的关键驱动因素和挑战是什么？
• 全球免疫血液学市场的结构如何？
• 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

• 研究目的
• 利害关係人
• 数据来源
  • 主要来源
  • 二手资料
• 市场预测
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第 3 章：执行摘要

第 4 章：简介

• 概述
• 主要行业趋势

第 5 章：全球免疫血液学市场

• 市场概况
• 市场表现
• COVID-19 的影响
• 市场预测

第 6 章：市场区隔：依产品

• 分析系统
  • 市场趋势
  • 市场预测
• 试剂及耗材
  • 市场趋势
  • 市场预测

第 7 章：市场区隔：依技术

• 生物晶片
  • 市场趋势
  • 市场预测
• 凝胶卡
  • 市场趋势
  • 市场预测
• 微孔板
  • 市场趋势
  • 市场预测
• 聚合酶炼式反应
  • 市场趋势
  • 市场预测
• 红血球磁化技术 (EMT)
  • 市场趋势
  • 市场预测
• 其他的
  • 市场趋势
  • 市场预测

第 8 章：市场区隔：按应用

• 血液相关疾病
  • 市场趋势
  • 市场预测
• 爱滋病
  • 市场趋势
  • 市场预测
• 肝炎
  • 市场趋势
  • 市场预测
• 输血
  • 市场趋势
  • 市场预测
• 其他的
  • 市场趋势
  • 市场预测

第 9 章：市场区隔：按最终用户

• 医院
  • 市场趋势
  • 市场预测
• 血库
  • 市场趋势
  • 市场预测
• 诊断实验室
  • 市场趋势
  • 市场预测
• 其他的
  • 市场趋势
  • 市场预测

第 10 章：市场区隔：按地区

• 北美洲
  • 美国
  • 加拿大
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
• 中东和非洲
  • 市场趋势
  • 市场细分：按国家/地区
  • 市场预测

第 11 章：SWOT 分析

• 概述
• 优势
• 弱点
• 机会
• 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

• 概述
• 买家的议价能力
• 供应商的议价能力
• 竞争程度
• 新进入者的威胁
• 替代品的威胁

第14章：竞争格局

• 市场结构
• 关键参与者
• 关键参与者简介
  • Abbott
  • Antisel
  • BD (Becton Dickinson and Company)
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols SA
  • Merck KGaA
  • MTC Invitro Diagnostics AG
  • Ortho-Clinical Diagnostics Inc (The Carlyle Group)
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.

The global immunohematology market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.

Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT).

The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices. Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunohematology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end-user.

Breakup by Product:

Analyzing Systems

Reagents and Consumables

Breakup by Technology:

Biochips

Gel Cards

Microplates

Polymerase Chain Reaction

Erythrocyte-Magnetized Technology (EMT)

Others

Breakup by Application:

Blood-Related Diseases

HIV

Hepatitis

Blood Transfusion

Others

Breakup by End-User:

Hospitals

Blood Banks

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

• How has the global immunohematology market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global immunohematology market?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global immunohematology market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Immunohematology Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Analyzing Systems
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Reagents and Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Biochips
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Gel Cards
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Microplates
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Polymerase Chain Reaction
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Erythrocyte-Magnetized Technology (EMT)
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Application

• 8.1 Blood-Related Diseases
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 HIV
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hepatitis
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Blood Transfusion
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Blood Banks
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Diagnostic Laboratories
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Antisel
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 BD (Becton Dickinson and Company)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Bio-Rad Laboratories Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 F. Hoffmann-La Roche Ltd.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 SWOT Analysis
  • 14.3.7 Grifols S.A.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Merck KGaA
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 MTC Invitro Diagnostics AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Ortho-Clinical Diagnostics Inc (The Carlyle Group)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 SWOT Analysis
  • 14.3.11 Siemens Healthcare GmbH
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Thermo Fisher Scientific Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis

List of Figures

• Figure 1: Global: Immunohematology Market: Major Drivers and Challenges
• Figure 2: Global: Immunohematology Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Immunohematology Market: Breakup by Product (in %), 2023
• Figure 4: Global: Immunohematology Market: Breakup by Technology (in %), 2023
• Figure 5: Global: Immunohematology Market: Breakup by Application (in %), 2023
• Figure 6: Global: Immunohematology Market: Breakup by End-User (in %), 2023
• Figure 7: Global: Immunohematology Market: Breakup by Region (in %), 2023
• Figure 8: Global: Immunohematology Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 9: Global: Immunohematology (Analyzing Systems) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Immunohematology (Analyzing Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Immunohematology (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Immunohematology (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Immunohematology (Biochips) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Immunohematology (Biochips) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Immunohematology (Gel Cards) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Immunohematology (Gel Cards) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Immunohematology (Microplates) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Immunohematology (Microplates) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Immunohematology (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Immunohematology (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Immunohematology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Immunohematology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Immunohematology (Blood-Related Diseases) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Immunohematology (Blood-Related Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Immunohematology (HIV) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Immunohematology (HIV) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Immunohematology (Hepatitis) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Immunohematology (Hepatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Immunohematology (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Immunohematology (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Immunohematology (Others) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Immunohematology (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Global: Immunohematology (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Global: Immunohematology (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Global: Immunohematology (Blood Banks) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Global: Immunohematology (Blood Banks) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Global: Immunohematology (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Global: Immunohematology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Global: Immunohematology (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Global: Immunohematology (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: North America: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: North America: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: United States: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: United States: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: Canada: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: Canada: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: Asia Pacific: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: Asia Pacific: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: China: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: China: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Japan: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Japan: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: India: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: India: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: South Korea: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: South Korea: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Australia: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Australia: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Indonesia: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Indonesia: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: Others: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Europe: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Europe: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Germany: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Germany: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 69: France: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 70: France: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 71: United Kingdom: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 72: United Kingdom: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 73: Italy: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 74: Italy: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Spain: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 76: Spain: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 77: Russia: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 78: Russia: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 79: Others: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 80: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 81: Latin America: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 82: Latin America: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 83: Brazil: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 84: Brazil: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 85: Mexico: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 86: Mexico: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 87: Others: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 88: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 89: Middle East and Africa: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
• Figure 90: Middle East and Africa: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 91: Global: Immunohematology Industry: SWOT Analysis
• Figure 92: Global: Immunohematology Industry: Value Chain Analysis
• Figure 93: Global: Immunohematology Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Immunohematology Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Immunohematology Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Immunohematology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
• Table 4: Global: Immunohematology Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 5: Global: Immunohematology Market Forecast: Breakup by End-User (in Million US$), 2024-2032
• Table 6: Global: Immunohematology Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 7: Global: Immunohematology Market: Competitive Structure
• Table 8: Global: Immunohematology Market: Key Players